| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 358.308 | 89 |
| GSM780708 | Untreated after 4 days (C2_1) | 383.44 | 89 |
| GSM780709 | Untreated after 4 days (C3_1) | 414.529 | 90 |
| GSM780719 | Untreated after 4 days (C1_2) | 345.304 | 89 |
| GSM780720 | Untreated after 4 days (C2_2) | 387.645 | 90 |
| GSM780721 | Untreated after 4 days (C3_2) | 395.639 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 392.738 | 90 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 355.582 | 89 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 409.554 | 90 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 434.802 | 91 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 359.865 | 89 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 406.465 | 90 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 376.149 | 89 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 361.731 | 89 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 357.556 | 89 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 357.82 | 89 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 335.899 | 88 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 334.418 | 88 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 426.568 | 90 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 352.43 | 89 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 381.927 | 89 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 381.867 | 89 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 406.967 | 90 |